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ABSTRACT
Bacteriophage serine integrases are extensively
used in biotechnology and synthetic biology for as-
sembly and rearrangement of DNA sequences. Ser-
ine integrases promote recombination between two
different DNA sites, attP and attB, to form recombi-
nant attL and attR sites. The ‘reverse’ reaction re-
quires another phage-encoded protein called the re-
combination directionality factor (RDF) in addition
to integrase; RDF activates attL × attR recombina-
tion and inhibits attP × attB recombination. We show
here that serine integrases can be fused to their cog-
nate RDFs to create single proteins that catalyse ef-
ficient attL × attR recombination in vivo and in vitro,
whereas attP × attB recombination efficiency is re-
duced. We provide evidence that activation of attL ×
attR recombination involves intra-subunit contacts
between the integrase and RDF moieties of the fu-
sion protein. Minor changes in the length and se-
quence of the integrase–RDF linker peptide did not
affect fusion protein recombination activity. The effi-
ciency and single-protein convenience of integrase–
RDF fusion proteins make them potentially very ad-
vantageous for biotechnology/synthetic biology ap-
plications. Here, we demonstrate efficient gene cas-
sette replacement in a synthetic metabolic pathway
gene array as a proof of principle.
INTRODUCTION
The rapidly advancing ields of biotechnology and synthetic
biology demand ever more sophisticated and eficient tools
for precise manipulation of DNA. Often, double-stranded
DNA molecules must be cut at deined positions and re-
joined in new ways, for example to assemble long arrays of
genes from shorter DNAmolecules, integrate speciic trans-
gene sequences into precise genomic locations, or rearrange
regulatory sequences to alter gene expression. The natural
‘DNA cut and paste’ enzymes known as site-speciic recom-
binases (SSRs) have been much exploited for these applica-
tions (1). Recently the serine integrases, a family of SSRs
derived from bacteriophages (2), have been used in many
applications because of their uniquely advantageous direc-
tional properties.
Bacteriophage integrases catalyse recombination be-
tween an attP site in the circularized phage DNA and an
attB site in the chromosome of the bacterial host cell, lead-
ing to an integrated prophage lanked by recombinant attL
and attR sites (2) (Figure 1A). The prophage persists in this
integrated state until lysogenic induction, when the inte-
grase promotes recombination between the attL and attR
sites, excising the phage genome as aDNA circle. The phage
then re-enters a lytic developmental cycle. Because inte-
grases promote recombination between two sites with dif-
ferent sequences (unlike many other SSRs), the recombi-
nant sites are different from the non-recombinant sites and
also each other. These differences can be exploited by the
integrase so as to favour integration at lysogeny and exci-
sion at lysogenic induction, a property called directional-
ity. Bacteriophage integrases fall into two families accord-
ing to their protein structures and mechanisms, called ty-
rosine integrases and serine integrases (3). The two families
are mechanistically and evolutionarily unrelated (2,4).
In contrast to tyrosine integrase systems which typically
have long attP sites and complex accessory protein require-
ments, the att sites for serine integrases are relatively short
(∼40–50 bp), and each att site binds a dimer of integrase
(2) (Figure 1B). Recombination takes place in a synaptic
complex where two att sites are held together by an inte-
grase tetramer, formed by dimer-dimer interactions. In the
absence of any other proteins, a serine integrase catalyses
attP× attB recombination but not the ‘reverse’ attL× attR
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recombination. However, another phage-encoded protein
called the recombination directionality factor (RDF)makes
protein-protein interactions with integrase that transform
its properties so that it selectively catalyses attL × attR re-
combination (Figure 1B). Directionality is thus switched
simply by the presence or absence of RDF. It is hypoth-
esized that binding of RDF to integrase induces protein
conformational changes that favour productive synapsis of
attL and attR sites, and disfavour productive attP × attB
synapsis (2). Current experimental evidence suggests that
optimal stimulation of attL× attR recombination by RDF
requires interaction of an RDF subunit with each subunit
of the tetramer (Figure 1B) (5–7).
Serine integrases have been widely adopted for applica-
tions in molecular genetics, biotechnology and synthetic
biology because of their directionality, recombination efi-
ciency, and simple DNA sequence requirements (3). Pub-
lished applications include assembly of long DNAmodules
(for example, to create arrays of genes encoding metabolic
pathway enzymes) (8–10), integration of exogenous DNA
modules into cellular genomic DNA and subsequent ma-
nipulation of the integrated DNA (1,3,11–13), and con-
struction of genetic logic and memory systems (3,14–20).
However, most of these applications have involved just attP
× attB recombination; the additional functionality of attL
× attR recombination has been much less exploited. There
are several reasons for this. First, relatively few RDFs have
been characterized compared to the large number of known
serine integrases, as they are very diverse proteins that are
much more dificult to identify than integrases (2,21). Sec-
ond, attL × attR recombination requires the presence of
integrase, RDF and substrate in appropriate stoichiomet-
ric ratio, complicating its use in vivo or in vitro. Third, attL
× attR recombination eficiency (conversion of substrate to
products) is usually lower than for attP × attB recombina-
tion. When no RDF is present, a typical integrase recom-
bines attP and attB sites eficiently and has no detectable
reverse activity on the attL, attR products. The presence of
RDF switches integrase to favour attL × attR recombina-
tion but does not completely block attP× attB recombina-
tion, either because of the intrinsic properties of the system
or because some integrasemolecules are not bound byRDF
(5). Conversion of attL × attR substrates may therefore be
incomplete.
Here, we aimed to optimize integrase–RDF interaction
and stoichiometry by linking the two proteins in a sin-
gle polypeptide. We hypothesized that such fusion proteins
would promote high-eficiency, highly directional attL ×
attR recombination, and would thus expand the utility of
serine integrase-based systems.
MATERIALS AND METHODS
Plasmids and DNA
Plasmids for in vitro analysis of integrase activity, contain-
ing two att sites, were constructed by inserting synthetic
double-stranded att site oligonucleotides into pFM122, us-
ing procedures as described (22,23) (Supplementary Figure
S1, Tables S1 and S2). The plasmids are named here accord-
ing to the type of their att sites; for example, pC31LRX
has C31 attL and attR sites (the ‘X’ is to distinguish these
in vitro substrates from the in vivo substrates described be-
low). In all the in vitro substrates used here, the att sites
are oriented ‘head to tail’, such that recombination results
in resolution of the substrate plasmid into two smaller cir-
cles (see Figure 3B). Supercoiled plasmid DNA was puri-
ied from transformed Escherichia coli DH5 cells, using a
Qiagen HiSpeed Midi kit according to the manufacturer’s
instructions. DNA concentrations were estimated by mea-
suring absorbance at 260 nm.
In vivo test substrates for detecting C31 integrase or
integrase–RDF fusion protein activity were made from
pFM141 (derived from pDB35; (24)), which contains a
pSC101 origin of replication, a kanamycin resistance gene,
and a galK gene lanked by unique restriction enzyme
sites allowing for insertion of the att recombination sites
as double-stranded synthetic oligonucleotides (Supplemen-
tary Figure S1, Table S1). These plasmids are named as de-
scribed above, with ‘del’ and ‘inv’ indicating predicted out-
come of recombination, which depends on the relative ori-
entation of the two att sites (see Figures 1A and 2A). For
example, pC31delLR has C31 attL and attR sites lank-
ing galK, oriented ‘head-to-tail’ such that recombination re-
sults in deletion of the galK segment, whereas the att sites in
pC31invLR are ‘head-to-head’, so recombination results
in inversion of the orientation of the galK segment. Similar
test substrates for Bxb1 integrase weremade by inserting att
site oligonucleotides into pMS183, a variant of pFM141
with a different set of cloning sites.
Plasmids for constitutive expression of integrases and
integrase–RDF fusion proteins in E. coli were con-
structed by inserting protein-coding DNA fragments be-
tween uniqueNdeI andAsp718 sites in pMS140, a low-level
expression vector with a pMB1 origin of replication (25).
Plasmids for constitutive expression of the RDFs (gp3 for
C31 integrase, and gp47 for Bxb1 integrase) were made
similarly by inserting appropriate coding sequences into
pEK76, which has a p15a (pACYC184) origin (25). The
C31 integrase sequence (including a C-terminal His-tag)
was derived from pARM010 (23,26) and the gp3 sequence
was cloned from pEY301 (6). Codon-optimized sequences
of Bxb1 integrase and its RDF gp47 were from GeneArt
(Invitrogen).
A DNA sequence encoding the C31 integrase–RDF
fusion protein (C31.Int-gp3) was made by joining the
coding sequences for C31 integrase and gp3 via an 18
bp linker sequence (ACTAGTAGATCTGGTACC) which
contains recognition sequences for the restriction endonu-
cleases SpeI, BglII and Acc65I (in that order), and is trans-
lated to a 6-amino acid peptide (TSRSGT) between the C-
terminal residue of C31 integrase and the second amino
acid residue in gp3 (Figure 1C). The same approach was
used to construct coding sequences for the Bxb1 integrase–
RDF fusion protein (Bxb1.Int-gp47) and ‘hybrid’ fusion
proteins C31.Int-gp47 and Bxb1.Int-gp3. Full sequences
of representative plasmids are in Supplementary Table S2.
Expression and puriication of integrases, RDFs and
integrase–RDF fusions
Overexpression plasmids for C31 integrase, integrase–
RDF fusion proteins, and gp47 were made by cloning cod-
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Figure 1. Recombination by serine integrases, and design of integrase–
RDF fusion recombinases. (A) The biological function of bacteriophage
serine integrases. Recombination between a site in the bacteriophageDNA
(attP) and a site in the bacterial genome (attB) results in integration of
the phage DNA into the bacterial genome. The integrated phage DNA
is lanked by two new recombination sites (attL and attR). Due to asym-
metry within the att site sequences, recombination occurs such that the
phage DNA is integrated in a speciic orientation (indicated by the brown
arrow). The ‘reverse’ process, excision of the integrated prophage DNA,
is also catalysed by the integrase, but requires a second phage-encoded
protein, the recombination directionality factor (RDF). (B) Mechanism of
integrase-mediated recombination. The attP and attB sites are each bound
by an integrase dimer (grey ovals), and the two dimers then interact to form
a synaptic tetramer (not shown). TheDNA strands are then broken and re-
joined at the centres of the sites to form attL and attR recombinants. The
ing sequences as described above into pET-28a(+) (No-
vagen), between the NdeI and XhoI sites. The proteins ex-
pressed from these plasmids have an N-terminal hexahisti-
dine tag (MGSSHHHHHHSSGLVPRGSHM followed by
integrase amino acid 2), to allow puriication via nickel
afinity chromatography. For Bxb1 integrase overexpres-
sion, the coding sequence with a C-terminal hexahistidine
tag (TSHHHHHH) was cloned into pSA1101 (24) between
the NdeI and Acc65I sites. pEY301 (6) was used for the
overexpression of gp3. All these plasmids confer kanamycin
resistance.
All the proteins used in this work were puriied by es-
sentially the same protocol. The strain BL21(DE3)pLysS
was transformed with the relevant overexpression plas-
mid. Starter cultures (2 × YT-broth (10 ml) containing
kanamycin (50 g/ml) and chloramphenicol (25 g/ml))
were inoculated from single transformant colonies and
grown overnight at 37◦C. An aliquot of starter culture (4
ml) was used to inoculate pre-warmed 2 × YT-broth con-
taining kanamycin and chloramphenicol (400 ml, in 2-l
conical lasks). The cultures were incubated at 37◦C with
shaking (250 rpm) until an optical density of 0.5–0.6 at
600 nm was reached. The cultures were then cooled down
rapidly to 20◦C, and integrase expression was induced by
adding isopropyl--D-thiogalactopyranoside (IPTG) (inal
concentration 0.5 mM). The cultures were then grown for
16 h at 20◦C, shaking at 200 rpm. Cells were harvested
by centrifugation at 4◦C. The resulting cell pellet (∼2 g)
was washed in 100 ml 20 mM Tris–HCl (pH 7.5), 10 mM
MgCl2, and the pellet was collected by centrifugation. The
washed pellet was resuspended in 25 ml of a buffer contain-
ing 20 mM sodium phosphate (pH 7.4), 1 M NaCl, 1 mM
dithiothreitol (DTT), 50 mM imidazole, 1.2 mM phenyl-
methylsulfonyl luoride (PMSF) and 1% (v/v) ethanol. The
suspension was cooled in ice, and the cells were broken
by sonication (Vibra-Cell instrument, Sonics and Materi-
als Inc.); 40% amplitude; 3 × 20-s bursts). The suspension
was centrifuged for 30 min at 4◦C, 48 000 g. The super-
natant was collected and passed through a 0.22 m ilter.
The solution containing the soluble protein was then puri-
ied by metal afinity chromatography using a 1 ml HisTrap
FF pre-packed column (GE Healthcare). The column was
equilibrated with 10 column volumes of Buffer A (20 mM
sodium phosphate (pH 7.4), 1MNaCl, 1mMdithiothreitol
(DTT) and 50 mM imidazole), at a constant low rate of 1
ml/min, prior to loading the protein solution, also in Buffer
A. Buffer A (25–30 ml) was then passed through the col-
umn to wash off unbound proteins and other cellular com-
ponents. Following establishment of a steady baseline (ab-
sorbance at 260 and 280 nm), bound proteinwas elutedwith
Buffer B (Buffer A, but with 500 mM imidazole), increas-
ing in a 0–100% linear gradient over 25 min. Purity of frac-
tionswas assessed by SDS-polyacrylamide gel electrophore-
sis. Selected fractions were dialysed against 1 l of Buffer C
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
reverse reaction occurs only in the presence of the RDF (smaller yellow
ovals) which binds to integrase and modiies its properties. (C) Design of
integrase–RDF fusion proteins; linker sequences between the C-terminus
of the integrase and the N-terminus of the RDF are as shown (in blue).
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Figure 2. Recombination by integrase–RDF fusion proteins in vivo. (A) The in vivo assay. Left panel: recombination of a deletion substrate. The product
galK-containing DNA circle (marked with an X) has no origin of replication, so is lost as the cells multiply; this results in a colony color change on
MacConkey galactose medium, which can be assessed by visual inspection (24). Right panel: recombination of an inversion substrate lips the orientation
of the galK gene, which does not alter the size of the plasmid (or galK phenotype) but changes the sizes of the restriction digest products. (B) Recombination
of attP× attB and attL× attR deletion substrates (pC31delPB and pC31delLR respectively) by C31 integrase and the integrase–RDF fusion protein
C31.Int-gp3 in vivo; colony color assay. (C–F) Analysis of in vivo recombination product DNA. Cells contained the plasmids indicated above the gel
images. Miniprep DNA recovered from cells was treated with ScaI, linearizing the recombinase expression plasmid(s) but not the substrate or product
plasmids, prior to 1.2% agarose gel electrophoresis. Samples in D were also treated with XhoI and PacI, to reveal inversion products. Expression plasmid
linear bands are labelled Int (integrase), Fus (fusion protein), gp3 (RDF). Other bands are labeled nr (non-recombinant, i.e. substrate), inv (inversion
product), del (deletion product). Mean extent of recombination and standard deviation (%) from quantitation of triplicate experiments are given below
each lane.
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Figure 3. Recombination by integrase–RDF fusion proteins in vitro. (A) SDS-PAGE analysis of puriied C31 and Bxb1 integrases, RDFs, and fusion
recombinases. Lane 1, C31.Int; lane 2, gp3; lane 3, C31.Int-gp3; lane 4, Bxb1.Int; lane 5, gp47; lane 6, Bxb1.Int-gp47. (B) Scheme illustrating the in
vitro recombination assay (substrate plasmid pC31LRX shown; other substrates are similar). Reaction products were digested with NruI prior to 1.2%
agarose gel electrophoresis. (C) Recombination of C31 attL × attR and attP× attB plasmid substrates by C31 integrase with or without gp3, or by the
fusion protein C31.Int-gp3, as indicated above the lanes. The band labelled clv derives from double-strand cleavage of some substrate by integrase at the
upper (unshaded) site as in Figure 2B. For the pC31PBX reactions (where this band is most obvious; lanes 7 and 8), this site is attP. (D) Recombination
of Bxb1 attL × attR and attP × attB plasmid substrates by Bxb1 integrase with or without gp47, or by the fusion protein Bxb1.Int-gp47. In parts C
and D, the inal integrase, fusion protein, and RDF concentrations were all 400 nM. The mean extent of recombination and standard deviation (%) from
quantitation of triplicate experiments are given below each lane.
(25mMTris–HCl (pH 7.5), 1 mMDTT, 1MNaCl and 50%
glycerol), for at least 6 h, then in a further 1 l of fresh Buffer
C for a further 6 h, and stored at –20◦C. Protein concen-
trations were estimated by measurement of absorbance at
280 nm and/or comparison with standards on discontinu-
ous SDS-polyacrylamide gels stained with Coomassie Bril-
liant Blue G-250. The puriied proteins were used without
removing the His tags.
In vivo recombination reactions
Assays for integrase-mediated recombination inE. coliwere
modiied from the method described (for zinc-inger recom-
binases) in Akopian et al. (27). Briely, the galK mutant E.
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coli strain DS941 was irst transformed with an appropriate
test substrate plasmid. Competent cells were prepared from
the substrate plasmid-containing strain, and these were
transformed with an integrase-expressing plasmid, or co-
transformed with integrase- and RDF-expressing plasmids.
Transformants were selected on MacConkey-galactose in-
dicator plates (MacConkey agar base (Difco) supplemented
with 1% galactose, kanamycin (50 g/ml; to select for the
substrate plasmid and its recombination product), ampi-
cillin (50 g/ml; to select for the integrase expression plas-
mid), and chloramphenicol (25 g/ml, to select for the
RDF expression plasmid when necessary). When the sub-
strate plasmid has att recombination sites arranged such
that recombination causes deletion of the galK gene, pale-
coloured (galK−) colonies on the indicator plates indicate
recombination proiciency, whereas red (galK+) colonies in-
dicate lack of recombination; see Figure 2A and B.
To determine the extent of in vivo recombination more
accurately, plasmid DNA was isolated. The cells on the
MacConkey-galactose agar plates were recovered by sus-
pending them in L-broth (1 ml per plate). An aliquot of
the suspension (1 l) was used to inoculate L-broth (10
ml), and this culture was incubated overnight at 37 ◦C with
kanamycin selection. Plasmid DNA was prepared using a
Qiagen miniprep kit. Samples of the plasmid DNA were
digested with appropriate restriction enzymes, then anal-
ysed by 1.2% agarose gel electrophoresis. All samples were
treated with ScaI, which linearizes the recombinase expres-
sion vectors but not the substrate or recombinant plasmids.
Products from cells containing inversion substrates were
additionally treated with XhoI and PacI to produce dis-
tinct DNA fragments from non-recombinant and recom-
binant molecules. Quantitation of bands on the gels was
as described (5). All experiments were performed in trip-
licate, starting with three separate transformations of the
integrase-expressing plasmid as described above.
In vitro recombination reactions and product analysis
Integrases, integrase–RDF fusion proteins, and gp3 were
each diluted at 0◦C in a buffer containing 25 mM Tris–HCl
(pH 7.5), 1 mM DTT, 1 M NaCl and 50% (v/v) glycerol.
Dilutions were stored at –20◦C. In a typical recombination
reaction, diluted integrase (∼4 M, 4.5 l) was added to
a solution (40 l) containing substrate plasmid DNA (20
g/ml), bovine serum albumin (100 g/ml), 50 mM Tris–
HCl (pH 7.5), 5 mM spermidine, and 0.1 mM EDTA. The
inal integrase concentration was thus approximately 400
nM.The sample was incubated at 30◦C for 60min. For reac-
tions in the presence of gp3, equal volumes of integrase (∼8
M) and gp3 (in the same buffer;∼8 M)were mixed thor-
oughly and kept on ice for 15min, then 4.5l of thismixture
(containing∼4 M of each protein) was added to the reac-
tions. Similar protocols were followed in reactions involving
mixtures of integrase and integrase–RDF fusion proteins;
see text for details. Reactions were terminated by heating
at 80◦C for 10 min. For analysis by restriction enzyme di-
gestion, aliquots of the reaction mixture (30 l) were mixed
with B103 buffer (90 mM Tris–HCl pH 7.5, 20 mMMgCl2;
28 l) prior to addition of NruI (New England Biolabs; 2
l, 20 units). The samples were then incubated at 37◦C for 2
h. Loading buffer (25mMTris–HCl (pH8.2), 20% (w/v) Fi-
coll, 0.5% sodium dodecyl sulfate, 5 mg/ml protease K and
0.25 mg/ml bromophenol blue; 7.5 l) was added to each
sample, and then the products were separated by agarose gel
electrophoresis and visualized as described (28,29). Digital
images of ethidium-stained gels were recorded using a Bio-
Rad GelDoc apparatus, and are shown in reverse contrast.
In vitro gene editing and product analysis
The methods for the cassette exchange experiments were as
described (8) (see also Figure 6). Recombination between
a CmR/ccdB fragment with attR sites at each end (4 nM)
and attL sites in p(BEIZY) (12 nM) was promoted in vitro
by a mixture of C31 integrase (200 nM) and gp3 (200
or 400 nM), or by C31.Int-gp3 fusion protein (200 nM).
Reactions (conditions as described in the previous section)
were for 1, 2 and 18 h. The reaction products were used
to transform E. coli DB3.1 cells by electroporation; trans-
formants were selected with ampicillin and chlorampheni-
col on L-agar plates. The numbers of colonies recovered
were counted and used as an assessment of the eficiency of
the integrase-catalysed in vitro reactions. The colonies from
each treatment were then pooled, miniprep DNA was pre-
pared, DNA samples were digested with PstI, and the di-
gestedDNAwas analysed by 1.2%agarose gel electrophore-
sis to reveal the proportion of plasmids with correct cassette
replacement.
RESULTS
Design of integrase–RDF fusion proteins, and activity in vivo
We chose to focus our studies on twowell-characterized ser-
ine integrases for which RDFs have been identiied; C31
integrase (605 amino acids) from a Streptomyces phage, and
Bxb1 integrase (500 amino acids) from a Mycobacterium
phage. RDFs are known to interact directly with their cog-
nate integrase protein (2,6,30,31), but the interacting sur-
faces of the proteins remain unidentiied. Current hypothe-
ses based onmutational analysis and crystallographic struc-
tures of the C-terminal part of a Listeria innocua phage (LI)
integrase bound to att site DNA (32–34) propose that the
interactions involve (or are close to) a coiled-coil domain of
the protein.We noted that the extreme C-terminus of the LI
integrase lies quite near the coiled-coil domain in the solved
structures, so an RDFmoiety attached here via a short lex-
ible peptide linker might be able to interact with the coiled-
coil domain of its own fusion protein molecule. However,
the LI integrase is the only one whose structure in complex
with DNA has been solved, and there are as yet no struc-
tures of the integrase–RDF interaction for any system. It
was therefore not possible tomodel integrase–RDF interac-
tions of our chosen systems in detail, so we decided to adopt
a simple strategy, attaching the RDF to the C-terminus of
integrase via a lexible linker peptide.
The 244-amino acid C31 RDF gp3 (6) was attached
to the C-terminus of C31 integrase via a 6-amino acid
lexible linker, making the 854-amino acid fusion protein
C31.Int-gp3 (Figure 1C). The activity of C31.Int-gp3
was tested using a standard assay in which E. coli cells are
Nucleic Acids Research, 2017 7
irst transformed with a test plasmid containing two re-
combination sites, and then a plasmid expressing the re-
combinase (24,35). Recombination of the test plasmid re-
sults in the deletion of a galK marker gene (Figure 2A,
left panel) and a consequent change of colony colour on
indicator plates. The substrate plasmid pC31delLR, con-
taining C31 attL and attR sites, was not recombined by
C31 integrase (red colonies), as expected in the absence of
the RDF gp3 (Figure 2B), whereas it was recombined efi-
ciently by the fusion protein C31.Int-gp3 (pale-coloured
colonies). A similar plasmid with attP and attB sites lank-
ing galK (pC31delPB) was recombined both by C31 in-
tegrase and C31.Int-gp3. Plasmid DNA from the colonies
on the plates was then analysed by agarose gel electrophore-
sis (Figure 2C). In accord with the observed colony colours,
the attL × attR test substrate pC31delLR was observed
to be mostly recombined in cells expressing C31.Int-gp3
(Figure 2C, lane 7), whereas it was mostly unrecombined in
cells expressing C31 integrase (Figure 2C, panel 6). The
low but reproducibly observable level of recombination of
this substrate by C31 integrase is curious, because in vitro,
C31 integrase does not promote attL × attR recombi-
nation at all; for example, see Figure 3. We suspect that
an unidentiied endogenous E. coli protein can substitute
weakly for gp3 to permit attL × attR recombination. As
expected, the attP × attB substrate pC31delPB was fully
recombined by unmodiied C31 integrase (Figure 2C, lane
2), but recombination in cells expressing the integrase–RDF
fusion protein C31.Int-gp3 (Figure 2C, lane 3), or inte-
grase and gp3 separately (Figure 2C, lane 4) was incomplete,
showing that the presence of the gp3 moiety of the fusion
protein or gp3 itself has an inhibitory effect.
We carried out another set of experiments using similar
test substrates in which the att sites lanking galK are in in-
verted repeat (head-to-head) rather than direct repeat. Re-
combination of these substrates does not delete the galK
segment, but instead inverts its orientation relative to the
remainder of the plasmid. The recombinant plasmid can
potentially recombine again, restoring the original ‘non-
recombinant’ DNA coniguration (Figure 2A, right panel).
Restriction enzyme digestion followed by gel electrophore-
sis of plasmid DNA isolated from E. coli cells reveals the
relative amounts of non-recombinant and recombinant test
plasmids. The attL × attR substrate pC31invLR was re-
combined eficiently (79%) in cells expressing the fusion
protein C31.Int-gp3 (Figure 2D, lane 6), but this plas-
mid was poorly recombined (6%) by C31 integrase itself
(Figure 2D, lane 5). In contrast, the attP × attB plasmid
pC31invPB was recombined eficiently (91%) by C31 in-
tegrase but less eficiently (22%) by C31.Int-gp3 (Figure
2D, panels 1–3). The gp3 moiety of the fusion protein thus
stimulates attL × attR recombination but inhibits attP ×
attB recombination, so that at equilibrium most of the in-
version substrate is in the coniguration with attP and attB
sites, regardless of whether the starting plasmid had attP
and attB, or attL and attR sites.
To test the general applicability of the integrase–RDF fu-
sion strategy, we used analogous methods to construct a fu-
sion protein of Bxb1 integrase and its RDF gp47 (Bxb1.Int-
gp47; Figure 1C). The Bxb1 and C31 RDFs gp47 and gp3
are unrelated proteins. Like itsC31 counterpart, Bxb1.Int-
gp47 promoted recombination of both attL × attR and
attP × attB substrates in vivo, whereas Bxb1 integrase it-
self promoted recombination of the attP × attB substrate
only (Figure 2E). Inhibition of attP × attB recombination
by the gp47 moiety of the Bxb1.Int-gp47 fusion protein was
not observed in this in vivo experiment.
Speciic effect of the RDF moiety on fusion protein activity
It was possible that the altered recombination properties of
the fusion proteins were caused by some non-speciic effect
of the integrase C-terminal extension, rather than by spe-
ciic integrase–RDF interactions. To test this idea, we made
‘RDF-swapped’ versions of both C31 and Bxb1 inte-
grases; that is, we linked gp47 to C31 integrase (C31.Int-
gp47), and gp3 to Bxb1 integrase (Bxb1.Int-gp3). Each of
these hybrid proteins fully recombined the attP× attB sub-
strate with sites recognized by its integrase moiety, but had
lower (C31.Int-gp47) or zero (Bxb1.Int-gp3) activity on
the corresponding attL × attR substrate (Figure 2F). We
conclude that full stimulation of the integrase to perform
eficient attL× attR recombination requires C-terminal fu-
sion to its own RDF.
In vitro recombination activity of integrase–RDF fusion pro-
teins
Experiments with integrase–RDF fusion proteins in vivo
might give misleading results if the RDF is present in the
cells as a free protein (due to proteolytic cleavage of the fu-
sion protein, or initiation of translation within the fusion
protein reading frame). To eliminate such possibilities, we
analysed the activities of the fusion proteins in an in vitro as-
say, where recombination of a plasmid substrate containing
a pair of att sites can be detected by restriction enzyme di-
gestion and gel electrophoresis of the products. SDS-PAGE
analysis of puriied C31.Int-gp3 showed a single polypep-
tide of the predicted molecular weight (97 kDa; Figure 3A).
This fusion protein promoted eficient (74%) recombina-
tion of the attL × attR substrate pC31LRX (Figure 3C,
lane 4). The extent of recombination was as high as when
a mixture of C31 integrase and gp3 was used (Figure 3C,
lane 3). Unmodiied C31 integrase (in the absence of gp3)
did not promote any recombination of this substrate (Fig-
ure 3C, lane 2). In contrast, C31 integrase promoted ef-
icient (74%) recombination of the attP × attB substrate
pC31PBX, but recombination by C31.Int-gp3 was less
eficient (50%); again, the extent of the reaction with the
C31.Int-gp3 fusion protein was similar to that observed
with integrase plus gp3 (Figure 3C, lanes 6–8). These results
conirm that the C31.Int-gp3 fusion protein does indeed
promote attL× attR recombination as a single polypeptide,
and that it has reduced attP × attB activity.
We also expressed and puriied the Bxb1.Int-gp47 fusion
protein (Figure 3A). Like its C31 equivalent, Bxb1.Int-
gp47 promoted attL × attR recombination in vitro, in con-
trast to Bxb1 integrase itself which was inactive on this sub-
strate (Figure 3D; compare lanes 4 and 2). Similarly, recom-
bination of an attP × attB substrate by the fusion protein
was reduced relative to unmodiied Bxb1 integrase (Figure
3D; compare lanes 8 and 6).
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Figure 4. Stimulation of integrase activity by RDF is intramolecular. (A)
Hypothetical intra-subunit or inter-subunit activating interactions of the
RDF and integrase moieties of an integrase–RDF fusion protein. The
diagrams represent the intermediate synaptic complex formed when two
integrase-bound att sites interact. Only one RDF moiety is shown in each
diagram, for clarity. The stimulated integrase subunit is in blue, and the
subunit donating the RDF moiety (where different) is in brown. (B) C31
integrase (400 nM) was added to pC31LRX substrate and the mixture
was incubated at room temperature for 5 min to allow binding and full oc-
cupation of the sites; then gp3 (lane 3), C31.Int(S12A)-gp3 (lane 4), or
Bxb1.Int-gp3 (lane 5) was added. The mixture was then incubated for 1
h at 30◦C, and the products were detected as in Figure 3. Mean extent of
recombination and standard deviation (%) from quantitation of triplicate
experiments are given below relevant lanes.
The integrase–RDF regulatory interaction is intramolecular
Our working hypothesis was that the RDFmoiety of the fu-
sion protein stimulates attL× attR recombination by bind-
ing to its attached integrase moiety (Figure 4A, left panel).
However, it was also possible that activation involves inter-
action of the RDF moiety of one fusion protein subunit
with the integrase moiety of another subunit. Figure 4A il-
lustrates two such inter-subunit scenarios; an RDF-donor
subunit could be part of the synaptic complex (the interme-
diate leading to strand exchange) (Figure 4A, centre panel),
or it could be an ‘extra’ subunit which is not part of the
synaptic complex (Figure 4A, right panel). We performed
an experiment in vitro to test for the latter scenario. The fu-
sion protein C31.Int(S12A)-gp3 has a mutation of the cat-
alytic serine residue S12 to alanine and is thus inactive (26),
but it could donate its RDF (gp3) moiety to stimulate attL
× attR recombination by unmodiied integrase. Unmodi-
ied C31 integrase was added irst to attL× attR substrate
plasmid, so that it would fully occupy the att sites. When
gp3 was then added to the mixture, eficient recombination
(69%) was observed (Figure 4B, lane 3), but recombination
was only barely detectable (<1%) when C31.Int(S12A)-
gp3was added (Figure 4B, lane 4). The gp3moiety of the fu-
sion protein is thus unavailable for stimulatory inter-subunit
interactions with the pre-bound unmodiied integrase.
A simple explanation of this result is that the gp3 moi-
ety of the fusion protein is sequestered by binding tightly
to its linked integrase moiety. To test this hypothesis, we
used a different fusion protein, Bxb1.Int-gp3, comprising
Bxb1 integrase linked to the C31 RDF gp3. This protein
(like Bxb1 integrase itself) does not bind to or recombine
C31 att sites (data not shown). Bxb1 integrase and gp3
are from unrelated bacteriophages, so we did not expect the
two parts of this fusion protein to interact strongly. When
Bxb1.Int-gp3 was added to pre-assembled complexes of the
C31 attL × attR substrate with C31 integrase, it stimu-
lated recombination (Figure 4B, lane 5). The gp3 moiety of
this protein is thus free to make inter-subunit interactions,
unlike that of the ‘all-C31’ fusion protein.
In summary, these results show that ‘extra’ subunits (not
bound to the att sites) are not involved in stimulation of
attL × attR recombination activity by the fusion proteins.
The simplest explanation of our observations is that the in-
tegrase and RDF parts of each fusion protein subunit in-
teract with each other (as in the left-hand panel of Figure
4A).
The integrase–RDF linker
The length and nature of the linker peptide connecting the
integrase and RDF moieties might be expected to be im-
portant factors affecting the properties of the fusion pro-
teins. The linkers used in our irst fusions (described above)
might have been fortuitously functional, but theymight also
be sub-optimal. We therefore made and tested fusion pro-
teins with two altered linker designs (Figure 5A; see also
Figure 1C). The sequence shown in bold in Figure 5A corre-
sponds to the most C-terminal identiied structural element
(-strand 14) of the large serine recombinases (33). InC31
integrase this element is followed by a inal 21-amino acid
sequence which is non-essential (36) and whose function (if
any) is unknown. Our original linker (L1) is a 6-amino acid
sequence connecting the C-terminus of C31 integrase to
theN-terminus of gp3 (minus its initial methionine residue).
Linker L2 includes an additional 12-amino acid (GSG)4 se-
quence, reported to be lexible (28,37,38). The third linker
L3 is similar to L1 except that the 21 amino acid residues
following -strand 14 have been deleted.
The activities of the three linker variants of the fusion
protein C31.Int-gp3 were compared in vivo. There were no
apparent differences in activity, as indicated by the colony
colour assay (Figure 5B); all three proteins were proicient
for recombination on both attP× attB and attL× attR sub-
strates. Similarly, examination of DNA isolated from cells
harbouring inversion substrates showed no differences in
activity; all three proteins recombined most of the attL ×
attR substrate, but had lower activity on the attP × attB
substrate (Figure 5C), consistent with our earlier results
(Figure 3). We conclude that, within the range we tested,
linker length and structure are not critical for fusion inte-
grase recombination activity.
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Figure 5. Variation of the integrase–RDF linker. (A) Variant linkers be-
tween the integrase and gp3 moieties of the fusion recombinase C31.Int-
gp3. Linker sequence is in blue (and red showing the lexible (GSG)4 se-
quence); gp3 sequence (starting at gp3 residue 2) is in brown. (B) Recom-
bination of a deletion substrate in E. coli by the variant-linker fusion pro-
teins. The assay is as shown in Figure 2A and B. (C) Products from in-
version substrates in E. coli were analysed by restriction enzyme digestion
and gel electrophoresis, as described in the legend for Figure 2D. Mean
extent of recombination and standard deviation (%) from quantitation of
triplicate experiments are given below each lane.
Gene array editing by integrase–RDF fusion recombinase
Integrase–RDF fusion recombinases might have many uses
in serine integrase-based methodologies for DNA manip-
ulation, as single proteins substituting for the two separate
proteins currently necessary to promote attL× attR recom-
bination (see Discussion). Here, as a proof of principle, we
show how an ordered array of genes assembled by integrase-
mediated attP × attB recombination can subsequently be
edited by fusion recombinase-mediated attL× attR recom-
bination.
We began with a plasmid (p(BEIZY)) made in previous
work (8,9), which contains an array of genes expressing en-
zymes for a metabolic pathway leading to the carotenoid
zeaxanthin. The ive carotenoid genes crtB, crtE, crtI, crtZ
and crtY were assembled (in this order) from PCR prod-
ucts using C31 integrase-mediated attP × attB recombi-
nation, so that each gene cassette in p(BEIZY) is lanked by
attL sites (Figure 6A). The assembly method relied on the
speciicity of serine integrases for recombination between
sites with identical nucleotides in the central 2 bp of the
att sites; as a result, each attL in the array has a different
central 2 bp (Figure 6A) (8). In order to replace one of the
gene cassettes (crtI) with a different sequence, we prepared
a PCR product consisting of a gene for chloramphenicol re-
sistance lanked by attR sites, with GT and CA central din-
ucleotides corresponding to the central dinucleotides of the
attL sites lanking crtI in the array. The crtI cassette is re-
placed by the chloramphenicol resistance cassette after two
attL× attR recombination reactions, one between the ‘GT’
sites and the other between the ‘CA’ sites (Figure 6A). A
mixture of p(BEIZY) and CmR PCR product was treated
with theC31.Int-gp3 fusion protein, or with integrase plus
gp3 (two different concentrations of gp3 were compared).
Aliquots of the reactions were stopped after 1, 2 and 18 h,
and the products were used to transform E. coli cells by a
standard protocol (8,9), selecting for ampicillin and chlo-
ramphenicol resistance. The numbers of colonies were then
counted (Figure 6B). The reactions with the fusion protein
and with integrase–gp3 mixtures for 1 or 2 h gave similar
transformant colony numbers, but the fusion protein gave
more colonies than the mixtures after 18-h reactions, indi-
cating a higher level of cassette exchange. PlasmidDNAwas
prepared from the pooled colonies from each transforma-
tion and analysed by digestion with PstI, to check that the
chloramphenicol resistance cassette was correctly inserted
into the array (Figure 6C). In all cases most of the plasmid
DNA had the expected structure (bands of 5636 and 1878
bp); other fainter bands, indicative of incorrect assembly or
post-assembly rearrangements, were evident in all the DNA
samples but were notably less abundant in the products of
fusion protein-mediated cassette exchange (Figure 6C).
DISCUSSION
TheC31 and Bxb1 integrase–RDF fusion proteins that we
constructed promote eficient attL × attR recombination,
in contrast to their parent integrases (which are completely
inactive on attL× attR substrates in vitro). The extent of fu-
sion protein-promoted attL× attR recombination observed
under optimal conditions was similar to that of the parent
integrase in the presence of a large excess of RDF. In con-
trast, attP × attB recombination activity of the fusion pro-
teins was reduced in comparison to the parent integrases.
Again, the reduction in activity was similar to that observed
when a high concentration of RDF was added to the un-
modiied integrase. These results, along with our further in
vitro complementation experiments, imply that the fusion
protein acts as a unitary enzyme, with the integrase and
RDF parts of each protein subunit binding to each other.
The length and sequence of the linker peptide between the
two domains of the fusion recombinase might therefore be
predicted to be important for optimal interactions, but we
did not observe any obvious differences in attL × attR re-
combination eficiency for the three linker variants of the
C31 integrase-gp3 fusion protein that we tested (Figure
5). We speculate that lexible or disordered regions at the C-
10 Nucleic Acids Research, 2017
Figure 6. Targeted editing of a gene array by an integrase–RDF fusion
recombinase. (A) integrase–RDF fusion protein-mediated replacement
of the crtI gene cassette in plasmid p(BEIZY) with a different cassette
(CmR/ccdB). p(BEIZY) contains an array of genes crtB, crtE, crtI, crtZ
and crtY, each separated by C31 attL sites differing in their central din-
ucleotide sequence (8). The linear PCR product (red, cartooned above the
arrow) contains the CmR/ccdB gene cassette (conferring chloramphenicol
resistance), lanked by C31 attR sites (attR-GT and attR-CA; yellow and
cyan triangles) with central dinucleotides matching the attL sites lanking
crtI. The usefulness of CmR/ccdB cassette exchange is described in (8); the
properties of the ccdB gene are not used in the experiments described here.
(B) Cassette substitution reactions were carried out in vitro with integrase
and gp3 or Int-gp3 fusion recombinase, for varying times, as indicated on
the igure. Reaction products were used to transform E. coli cells, transfor-
mants were selected on plates containing ampicillin and chloramphenicol,
and colonies were counted. Each bar in the igure represents mean± stan-
dard deviation from three experiments. (C) Plasmid DNA was recovered
from the pooledE. coli colonies (as in B) and digested with PstI. The digest
products were separated by agarose gel electrophoresis, and the proportion
(%) of correctly assembled plasmids was estimated by quantitation of the
bands. Quantitation values and standard deviation from triplicate experi-
ments are given below each lane.
terminus of C31 integrase and/or the N-terminus of gp3
contribute to the effective length and lexibility of the inter-
domain linker, negating any effects of the relatively small
variations that we tested. These results suggest that con-
struction of similar fusion recombinases from other serine
integrases will be straightforward as the linker design is not
a critical factor.
We successfully created functional fusion recombinases
from two different integrases (C31 and Bxb1), and we
are conident that the same strategy could be applied to
many other serine integrases. It may thus become rou-
tine to use two recombinase proteins in serine integrase-
based applications, integrase for attP × attB recombina-
tion and integrase–RDF fusion for attL × attR recombi-
nation, rather than using integrase for both but comple-
menting with RDF for the attL× attR reaction. This dual-
recombinase methodology should be advantageous for sev-
eral reasons. First, comparable expression levels of the two
proteins in vivo should be easily achievable using identical
promoters, which might be switched on or off alternately by
a genetic circuit. Second, on expression of the fusion pro-
tein, the integrase–RDF stoichiometry is ixed at the pre-
dicted optimal value of 1:1 (5), whereas the level of RDF
must be adjusted for optimal performance in any experi-
mental system when it is expressed separately (15). Third,
RDF-integrase contacts favouring attL × attR recombina-
tion are expected to be maximized by intramolecular link-
age of the two proteins. Fourth, fusion of the RDF with the
integrase might eliminate problems of RDF toxicity, aggre-
gation or instability in both in vitro and in vivo applications.
We have shown here how an integrase–RDF fusion re-
combinase can be used for eficient editing of gene arrays
assembled by SIRA methodology (8) (Figure 6). We envis-
age many similar applications, where the fusion recombi-
nase is used for subsequent manipulations of products of
attP × attB recombination which contain DNA compo-
nents bounded by attL and/or attR sites. integrase–RDF
fusion recombinases may prove to be especially useful for
genetic switches, circuits, logic and memory systems (14–
20). For example, an invertible DNA segment in PB ori-
entation (that is, bounded by attP and attB sites) may be
‘lipped’ repeatedly into the LR orientation and back again
by transient bursts of integrase and then integrase–RDF fu-
sion recombinase.
The integrase–RDF fusion recombinase might be a use-
ful platform for future work to enhance the eficiency and
directionality of attL × attR recombination by protein en-
gineering or directed evolution. It could also be used in ge-
netic screens to identify the RDFs for integrases; candidate
RDF reading frames could simply be cloned at the inte-
grase C-terminus and the fusion protein activity could then
be tested in E. coli. Similarly, it might be possible to ind
synthetic RDFs by cloning libraries of peptide-coding frag-
ments at the integrase C-terminus and selecting for attL ×
attR recombination activity. We also envisage systems for
conditional creation of fusion recombinases from integrase
and RDF components by split-gene reassembly, or post-
translationally by intein splicing technology.
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